GeneDx Holdings Corp (WGS)
78.71
+6.64
(+9.21%)
USD |
NASDAQ |
Nov 22, 16:00
78.78
+0.07
(+0.09%)
After-Hours: 20:00
GeneDx Holdings Shareholders Equity (Quarterly): 204.50M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 204.50M |
| June 30, 2024 | 194.04M |
| March 31, 2024 | 207.22M |
| December 31, 2023 | 228.02M |
| September 30, 2023 | 254.26M |
| June 30, 2023 | 296.11M |
| March 31, 2023 | 328.47M |
| Date | Value |
|---|---|
| December 31, 2022 | 253.70M |
| September 30, 2022 | 561.29M |
| June 30, 2022 | 637.27M |
| March 31, 2022 | 329.44M |
| December 31, 2021 | 388.10M |
| September 30, 2021 | 391.26M |
| December 31, 2020 | -330.05M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-330.05M
Minimum
Dec 2020
637.27M
Maximum
Jun 2022
281.69M
Average
275.19M
Median
Shareholders Equity (Quarterly) Benchmarks
| Spok Holdings Inc | 156.29M |
| Ontrak Inc | 11.46M |
| DarioHealth Corp | 58.51M |
| National Research Corp | 34.62M |
| FOXO Technologies Inc | -17.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 408.84M |
| Total Liabilities (Quarterly) | 204.34M |
| Debt to Equity Ratio | 0.2544 |
| Current Ratio | 2.405 |
| Net Debt Paydown Yield | -0.79% |